Sorrento Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2023.
  • Sorrento Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$95.2M, a 56.5% increase year-over-year.
  • Sorrento Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$548M, a 4.64% decline year-over-year.
  • Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$573M, a 33.7% decline from 2021.
  • Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$428M, a 43.5% decline from 2020.
  • Sorrento Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$298M, a 2.19% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$548M -$95.2M +$124M +56.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$672M -$140M -$98.8M -242% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$573M -$224M -$79.3M -54.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$494M -$89.6M +$30.2M +25.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$524M -$219M -$52.1M -31.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$472M -$40.8M -$43.3M -1726% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$428M -$144M -$72.9M -102% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 -$355M -$120M -$35.8M -42.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$320M -$167M -$88.9M -114% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$231M $2.51M +$67.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$298M -$71.5M -$8.68M -13.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$290M -$84M -$19.6M -30.4% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 -$270M -$77.7M -$21M -37% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 -$249M -$65.2M +$42.9M +39.7% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
Q4 2019 -$292M -$62.8M -$13M -26.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 -$279M -$64.4M -$17.1M -36.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-19
Q2 2019 -$262M -$56.8M +$17.1M +23.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-19
Q1 2019 -$279M -$108M -$75.5M -232% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-19
Q4 2018 -$204M -$49.8M -$98.2M -203% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$105M -$47.3M -$45.3M -2196% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$60.1M -$73.9M -$59.7M -421% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$378K -$32.6M -$9.51M -41.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 $9.13M $48.4M +$66.3M Oct 1, 2017 Dec 31, 2017 8-K 2019-06-17
Q3 2017 -$57.2M -$2.06M -$18M -113% Jul 1, 2017 Sep 30, 2017 8-K 2019-06-17
Q2 2017 -$39.2M -$14.2M +$29.1M +67.2% Apr 1, 2017 Jun 30, 2017 8-K 2019-06-17
Q1 2017 -$68.3M -$23.1M -$7.41M -47.4% Jan 1, 2017 Mar 31, 2017 8-K 2019-06-17
Q4 2016 -$60.9M -$17.9M +$5.62M +23.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$66.5M $15.9M +$16.8M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$83.4M -$43.3M -$32.3M -295% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$51M -$15.7M -$5.21M -49.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$45.8M -$23.5M -$15M -176% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$30.8M -$939K +$6.67M +87.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$37.5M -$11M -$2.5M -29.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$35M -$10.4M -$345K -3.42% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$34.7M -$8.51M +$2.79M +24.7% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
Q3 2014 -$37.4M -$7.61M -$4.25M -127% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$33.2M -$8.45M -$3.72M -78.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$29.5M -$10.1M -$7.57M -300% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$21.9M -$11.3M -$9.54M -544% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$12.4M -$3.36M -$2.11M -170% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$10.3M -$4.74M -$3.79M -402% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$6.46M -$2.52M -$1.62M -178% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$4.85M -$1.75M -$992K -130% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$3.85M -$1.24M -$539K -76.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.31M -$943K +$145K +13.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$3.46M -$906K -$222K -32.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$3.24M -$763K Oct 1, 2011 Dec 31, 2011 10-Q 2014-08-06
Q3 2011 -$702K -$257K -57.9% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-08
Q2 2011 -$1.09M -$512K -89% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$684K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$445K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$576K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.